Tirzepatide, a medication approved in the US as Zepbound for weight loss and Mounjaro for diabetes, was found to reduce the risk of diabetes progression by 94% in adults with prediabetes, obesity, or overweight when taken weekly, as compared to a placebo, according to a three-year study conducted by drugmaker Eli Lilly.

Related Videos :







The Weight Loss Drug That Prevents Diabetes [bPEtY7uMc]

The Weight Loss Drug That Prevents Diabetes [bPEtY7uMc]

Tirzepatide, a medication approved in the US as Zepbound for weight loss and Mounjaro for diabetes, was found to reduce the risk of diabetes progression by 94% in adults with prediabetes, obesity, or overweight when taken weekly, as compared to a placebo, according to a three-year study conducted by drugmaker Eli Lilly.

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now